Children’s Immune Response More Effective Against COVID-19
The new study, which examined serum and cell samples obtained from pediatric and adult patients diagnosed with COVID-19, found that children actually express higher levels of two specific immune system molecules. The researchers believe this may contribute to the better outcomes.Source: YaleNews
Yale Researchers to Lead $52M Investigation Into Cause, Effect of Schizophrenia in Some High-risk Adolescents
Researchers with the Yale Department of Psychiatry will lead an international study to better understand the cause and effect of schizophrenia in some high-risk adolescents and young adults.
I'm Working on a COVID-19 Vaccine
From April, I led clinical trials on Remdesivir, a therapeutic drug that was granted emergency approval by the Food and Drug Administration (FDA) for treatment of COVID-19, and since August 26 I have been running trials of a vaccine for COVID-19 prevention at Yale New Haven Hospital.Source: Newsweek
Drugging the Undruggable: Yale Finds Treatment Path for Muscular Dystrophy
Researchers at Yale have identified a possible treatment for Duchenne muscular dystrophy (DMD), a rare genetic disease for which there is currently no cure or treatment, by targeting an enzyme that had been considered “undruggable.”Source: YaleNews
You Can Catch COVID This Way After All
Eugene Shapiro, MD, a Yale Medicine pediatric infectious disease expert and professor of pediatrics at Yale School of Medicine, explains to Eat This, Not That! Health that children not only become infected with the virus, but are 100 percent capable of spreading it to others.Source: Eat This, Not That!
Gelernter, Polimanti New Editors-in-Chief of Complex Psychiatry
Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience; and Renato Polimanti, PhD, Assistant Professor of Psychiatry, will co-lead the journal Complex Psychiatry, which recently changed its name from Molecular Neuropsychiatry.
Quick and Affordable Saliva-based COVID-19 Test Developed by Yale Scientists Receives FDA Emergency Use Authorization
A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food and Drug Administration (FDA).Source: YaleNews
African American Adherence to COVID-19 Public Health Recommendations
African Americans' level of adherence with COVID-19 public health recommendations suggests they may be at high risk of a resurgence of COVID-19 during reopening, and there is an urgent need for targeted, culturally responsive public health messaging that is accessible to communities of color to help address racial disparities in COVID-19 risk.Source: Healio